Chemical Structure : Brevilin A
CAS No.: 16503-32-5
Catalog No.: PC-25382Not For Human Use, Lab Use Only.
Brevilin A is an orally active STAT3/JAK inhibitor with IC50 of 10.6 uM (STAT3), exerts potent anti-inflammatory, antitumor, immunosuppressive, and anti-liver fibrosis effects, also reduces protein levels of LRRC15 in RA fibroblast-like synoviocytes (RA-FLSs).
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $138 | In stock | |
10 mg | $218 | In stock | |
25 mg | $378 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Brevilin A is an orally active STAT3/JAK inhibitor with IC50 of 10.6 uM (STAT3), exerts potent anti-inflammatory, antitumor, immunosuppressive, and anti-liver fibrosis effects, also reduces protein levels of LRRC15 in RA fibroblast-like synoviocytes (RA-FLSs).
Brevilin A is reported to regulate the SIRT1/Nrf2/GPX4 signaling pathway to inhibit the production of MMP1 and MMP3 and alleviate joint damage in mice.
Brevilin A effectively alleviates LPS-induced lung damage, inflammatory infiltration, and the production of proinflammatory cytokines in LPS-induced acute lung injury.
Brevilin A significantly reduced the protein levels of LRRC15 in TNF-α-induced RA fibroblast-like synoviocytes (RA-FLSs).
Brevilin A significantly inhibited STAT3 phosphorylation without affecting total STAT3 protein levels
Brevilin A ameliorates arthritis symptoms in CIA rats.
M.Wt | 346.42 | |
Formula | C20H26O5 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(3S,3aR,4S,4aR,7aR,8R,9aR)-3,4a,8-Trimethyl-2,5-dioxo-2,3,3a,4,4a,5,7a,8,9,9a-decahydroazuleno[6,5-b]furan-4-yl (Z)-2-methylbut-2-enoate |
1. Chen X, et al. PLoS One. 2013 May 21;8(5):e63697.
2. Qiao Z, et al. Arthritis Res Ther. 2025 Aug 20;27(1):167.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright